 
             
                产品热线
                        电       话:400-8100-520
                        邮       箱:mi@sinocelltech.com 
                    商务合作
                        邮       箱:bd@sinocelltech.com
                        公司地址:北京经济技术开发区科创七街31号
                    A novel virus‐like particle (VLP)‐d multivalent recombinant human ...
As of April 2023 the SARS-CoV-2 infections remain a persistent gl...
The safety and immunogenicity of a protein-d tetravalent vaccine ...
COVID-19 lung pathology is characterized by interstitial pneumoni...
Adjuvants are an essential component in the development of highly ...
Immune checkpoint inhibitors (ICIs) such as anti-programmed cell ...
The vascular endothelial growth factor (VEGF) particularly VEGF-A ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led t...